The American Journal of Managed Care > February 2014
The American Journal of Managed Care - February 2014
February 20, 2014 – Alyna T. Chien, MD, MS; Marshall H. Chin, MD, MPH; G. Caleb Alexander, MD, MS; Hui Tang, MS; and Monica E. Peek, MD, MPH
Financial incentives alter the quality and quantity of care that physicians provide. Understanding physicians' recent experience with incentives may help shape current payment reform efforts.
February 19, 2014 – Bruce W. Sherman, MD; and Wendy D. Lynch, PhD
Organizations can better understand the link between workforce health and business performance by thoughtful integration of relevant metrics from both HR and business operations.
LETTERS TO THE EDITORS
February 19, 2014 – Jessica A. Eng, MD; Cecily J. Hunter, BA; Margaret A. Handley, PhD; Christy K. Boscardin, PhD; Ralph Gonzales, MD; and Sara L. Ackerman, PhD
February 20, 2014 – Yelba M. Castellon, MD; Shahrzad Bazargan-Hejazi, PhD; Miles Masatsugu, MD; and Roberto Contreras, MD
Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.
Complying With State and Federal Regulations on Essential Drug Benefits: Implementing the Affordable Care Act
February 20, 2014 – Joshua P. Cohen, PhD; Abigail Felix, BA; and Magdalini Vasiadi, PhD
Essential health benefits form a cornerstone of the Affordable Care Act. Our study shows that health plans in California and Massachusetts are not fully compliant with state and federal regulations on essential drug benefits.
TRENDS FROM THE FIELD
February 20, 2014 – Peter Cunningham, PhD; and Emily Carrier, MD
Decreased out-of-pocket spending on prescription drugs accounts for reduced financial burden of care to patients, and is consistent with improved access to care.
Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in Medicaid
February 24, 2014 – Seth A. Seabury, PhD; Dana P. Goldman, PhD; Iftekhar Kalsekar, PhD; John J. Sheehan, PhD; Kimberly Laubmeier, PhD; and Darius N. Lakdawalla, PhD
Retrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs.
February 25, 2014 – Rita L. Hui, PharmD, MS; Brian D. Yamada, PharmD; Michele M. Spence, PhD; Erwin W. Jeong, PharmD; and James Chan, PharmD, PhD
A pharmacist-led Medicare Medication Therapy Management program can improve clinical outcomes in Medicare beneficiaries without an increase in medication costs.
February 25, 2014 – Min Tao, PhD; Krishna Rangarajan, MS; Michael L. Paustian, PhD, MS; Elizabeth A. Wasilevich, PhD, MPH; and Darline K. El Reda, DrPH, MPH
Small weight loss was reported by overweight/obese individuals targeted for telephonic wellness coaching in this large retrospective study using pre-post design.
February 26, 2014 – Kari L. Olson, BSc(Pharm), PharmD; Michele D. Wood, PharmD; Thomas Delate, PhD; Lisa J. Lash, PharmD; Jon Rasmussen, PharmD; Anne M. Denham, PharmD; and John A. Merenich, MD
This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.